chloroquine has been researched along with sulfinpyrazone in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (46.15) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
| Glusa, E | 1 |
| Join, F; Tremblay, F | 1 |
| Gagnon, FT; Jobin, F | 1 |
| Graeme, ML; John, M; Sigg, EB | 1 |
| Evensen, SA; Galdal, KS; Nilsen, E | 1 |
| BERNTSEN, K; BOSTROEM, H; WHITEHOUSE, MW | 1 |
1 review(s) available for chloroquine and sulfinpyrazone
| Article | Year |
|---|---|
[Inhibition of blood platelet function].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antimalarials; Aspirin; Chloroquine; Dipyridamole; Female; Humans; Maternal-Fetal Exchange; Platelet Aggregation; Pregnancy; Sulfinpyrazone; Vasodilator Agents | 1979 |
12 other study(ies) available for chloroquine and sulfinpyrazone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
Platelet reactions and immune processes. II. The inhibition of platelet aggregation by complement inhibitors.
Topics: Aldehydes; Blood Platelets; Catechols; Cell Membrane; Chloroquine; Colchicine; Collagen; Complement Fixation Tests; Complement Inactivator Proteins; Guaiacol; Humans; Latex Fixation Tests; Lupus Erythematosus, Systemic; ortho-Aminobenzoates; Phenylbutazone; Platelet Adhesiveness; Resorcinols; Salicylates; Silicones; Sodium; Sulfinpyrazone | 1969 |
Platelet reactions and immune processes. IV. The inhibition of complement by pyrazole compounds and other inhibitors of platelet reactions.
Topics: Animals; Blood Coagulation; Blood Platelets; Chloroquine; Complement Inactivator Proteins; Erythrocytes; Guinea Pigs; Hemolysis; Hydroxychloroquine; In Vitro Techniques; Inflammation; Oxyphenbutazone; Sheep; Sulfinpyrazone; Thrombosis | 1970 |
Induction of periarthritis by oral administration of 6-sulfanilamidoindazole and its treatment in rats.
Topics: Animals; Aspirin; Chloroquine; Cloxacillin; Hydralazine; Hydrocortisone; Indomethacin; Male; Mercaptopurine; Methotrexate; Morphine; ortho-Aminobenzoates; Oxyphenbutazone; Paramethasone; Periarthritis; Phenylbutazone; Rats; Sulfinpyrazone; Sulfonamides | 1967 |
Injury to cultured human fibroblasts induced by low density lipoproteins: potentiating and protective factors.
Topics: Cells, Cultured; Chloroquine; Cholesterol Esters; Chromium Radioisotopes; Fibroblasts; Humans; Lipoproteins, LDL; Sulfinpyrazone; Ultracentrifugation | 1982 |
BIOCHEMICAL PROPERTIES OF ANTI-INFLAMMATORY DRUGS-II. SOME EFFECTS ON SULPHATE-35S METABOLISM IN VIVO.
Topics: Adenosine Triphosphate; Adrenocorticotropic Hormone; Anti-Inflammatory Agents; Antipyrine; Autoradiography; Benzoates; Cartilage; Chloroquine; Chromatography; Dicumarol; Dinitrophenols; Glycosaminoglycans; Hydrocortisone; Inflammation; Kidneys, Artificial; Metabolism; ortho-Aminobenzoates; Oxyphenbutazone; Phenylbutazone; Pyrazoles; Quinolines; Rats; Research; Sodium Salicylate; Sulfates; Sulfinpyrazone; Sulfur Isotopes; Uricosuric Agents; Urine | 1964 |